GlaxoSmithKline PLC Director/PDMR Shareholding (2280J)

TIDMGSK

RNS Number : 2280J

GlaxoSmithKline PLC

01 April 2015

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc ('Company').

On 31 March 2015, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of GBP15.66 per Ordinary Share, and notional ADSs at a price of $46.80 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2015 to 31 March 2015:

 
 Non Executive         Ordinary 
  Director              Shares     No. of ADSs 
 
 Sir Christopher 
  Gent                 3,991.060 
 
 Professor Sir 
  Roy Anderson           458.972 
 
 Dr Stephanie Burns                    486.201 
 
 Stacey Cartwright       339.240 
 
 Lynn Elsenhans                      1,103.464 
 
 Sir Philip Hampton      339.240 
 
 Judy Lewent                           539.049 
 
 Sir Deryck Maughan                  1,479.741 
 
 Dr Daniel Podolsky                  1,109.806 
 
 Urs Rohner              339.240 
 
 Tom de Swaan            419.061 
 
 Jing Ulrich                           306.518 
 
 Hans Wijers             339.240 
 
 

The Company and the Non-Executive Directors were informed of these allocations on 1 April 2015.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 April 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEFLFBEZFBBBV